Pliant Therapeutics, Inc.Pliant Therapeutics, Inc.Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc.

No trades
See on Supercharts

Price target

40.180.000.00%
The 11 analysts offering 1 year price forecasts for PLRX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 13 analysts giving stock ratings to PLRX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


PLRX EPS for the last quarter is −0.95 USD despite the estimation of −0.97 USD. In the next quarter EPS is expected to reach −0.99 USD. Track more of Pliant Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Pliant Therapeutics, Inc. revenue is expected to reach ‪125.00 K‬ USD. Check out Pliant Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, PLRX price target is 40.18 USD with a max estimate of 47.00 USD and a min estimate of 32.00 USD. Check if this forecast comes true in a year, meanwhile watch Pliant Therapeutics, Inc. stock price chart and keep track of the current situation with PLRX news and stock market news.
We've gathered opinions of 13 analysts rating PLRX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.